This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

SSR149415

Sanofi

Drug Names(s): SSR149415

Description: SSR149415 is a selective and orally active non-peptide antagonist of vasopressin V(1b) receptors. Through pituitary and central vasopressin V1b receptors, vasopressin participates in the control of the hypothalamic-pituitary-adrenal axis (HPA) and is involved in various emotional processes. SSR149415 potently antagonizes functional cellular events associated with V1b receptor activation by vasopressin, such as intracellular Ca2+ increase or proliferation in various cellsystems.


SSR149415 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug